Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

The Chemours Company (CC.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-04-01	32.26	38.00	Neutral
2022-04-07	31.62	35.00	Neutral
2022-05-02	33.10	38.00	Neutral
2022-05-17	42.82	41.00	Neutral
2022-07-12	31.70	35.00	Neutral
2022-07-28	34.90	37.00	Neutral
2022-10-11	26.53	29.00	Neutral
2023-01-11	32.96	31.00	Neutral
2023-01-23	33.92	43.00	Buy
2023-02-09	33.50	45.00	Buy
2023-04-11	30.18	41.00	Buy
2023-06-12	31.45	43.00	Buy
2023-07-27	37.95	47.00	Buy
2023-10-09	25.81	41.00	Buy
2023-10-26	24.24	37.00	Buy
2024-03-04	20.19	21.00	Neutral
2024-04-01	28.74	28.00	Neutral
2024-07-09	22.45	30.00	Buy
2024-08-05	18.75	28.00	Buy
2024-10-07	20.07	26.00	Buy
2025-02-18	17.48	24.00	Buy
2025-04-07	10.53	18.00	Buy
2025-05-06	12.10	17.00	Buy

Disclosures

UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and investment banking services are being, or have been, provided.
UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.